Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ADMA BIOLOGICS, INC. (ADMA)

  • Business News
  • Aug. 10, 2026, 07:38 UTC
  • 1
  • 1 comments

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

Market reaction Comment Full text

VIA TRANSPORTATION, INC. (VIA)

  • Business News
  • Aug. 10, 2026, 07:34 UTC
  • 1
  • 1 comments

VIA Investors Have Opportunity to Lead Via Transportation, Inc. Securities Fraud Lawsuit with SBS Law

Market reaction Comment Full text

OCULIS HOLDING AG (OCS)

  • Business News
  • Aug. 10, 2026, 07:30 UTC
  • 1
  • 1 comments

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

Market reaction Comment Full text

DIGITAL REALTY TRUST, INC. (DLR)

  • Business News
  • Aug. 10, 2026, 07:24 UTC
  • 1
  • 1 comments

Ekstraordinære indfrielser (CK 93)

Market reaction Comment Full text

RP OPTICAL LAB LTD (RPOL)

  • Business News
  • Aug. 10, 2026, 07:14 UTC
  • 1
  • 1 comments

Started to be an interested party - Migdal Insurance and Financial Holdings Ltd.

Market reaction Comment Full text

MEGA OR HOLDINGS LTD (MGOR)

  • Business News
  • Aug. 10, 2026, 07:09 UTC
  • 1
  • 1 comments

Presentation to the capital market - second quarter of 2026

Market reaction Comment Full text

PRUDENTIAL PLC (K6S)

  • Business News
  • Aug. 10, 2026, 07:08 UTC
  • 2
  • 1 comments

General Announcement: Transaction in own shares

Market reaction Comment Full text

PAYSAFE LIMITED COMMON SHARES (PSFE)

  • Business News
  • Aug. 10, 2026, 07:05 UTC
  • 1
  • 1 comments

PaysafeWallet Is Now Live in Poland: Your Money, Your Way

Market reaction Comment Full text

ANCHUN INTERNATIONAL HOLDINGS LTD. (BTX)

  • Business News
  • Aug. 10, 2026, 07:04 UTC
  • 1
  • 1 comments

Financial Statements and Related Announcement: Profit Guidance

Market reaction Comment Full text

OCULIS HOLDING AG (OCS)

  • Business News
  • Aug. 10, 2026, 07:01 UTC
  • 1
  • 1 comments

Oculis undirritar kaupsamning við Accure Therapeutics um leiðandi þróunarlyfið Privosegtor og eflir þannig stöðu Oculis sem leiðandi vaxtarfyrirtækis á sviði taugaaugnlækninga

Market reaction Comment Full text
  • Previous
  • 488
  • 489
  • 490
  • 491
  • 492
  • Next

Search

News categories

  • Technical Exchange News(14281)
  • Event(6229)
  • SEC News(370799)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(227253)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin